Tyrosine receptor kinase B receptor activation reverses the impairing effects of acute nicotine on contextual fear extinction

Journal of Psychopharmacology
Munir Gunes KutluThomas J Gould

Abstract

Anxiety and stress disorders have been linked to deficits in fear extinction. Our laboratory and others have demonstrated that acute nicotine impairs contextual fear extinction, suggesting that nicotine exposure may have negative effects on anxiety and stress disorder symptomatology. However, the neurobiological mechanisms underlying the acute nicotine-induced impairment of contextual fear extinction are unknown. Therefore, based on the previous studies showing that brain-derived neurotrophic factor is central for fear extinction learning and acute nicotine dysregulates brain-derived neurotrophic factor signaling, we hypothesized that the nicotine-induced impairment of contextual fear extinction may involve changes in tyrosine receptor kinase B signaling. To test this hypothesis, we systemically, intraperitoneally, injected C57BL/6J mice sub-threshold doses (2.5 and 4.0 mg/kg) of 7,8-dihydroxyflavone, a small-molecule tyrosine receptor kinase B agonist that fully mimics the effects of brain-derived neurotrophic factor, or vehicle an hour before each contextual fear extinction session. Mice also received injections, intraperitoneally, of acute nicotine (0.18 mg/kg) or saline 2-4 min before extinction sessions. While the animals ...Continue Reading

References

Dec 1, 1991·Archives of General Psychiatry·N BreslauP Andreski
Mar 1, 1969·Journal of Comparative and Physiological Psychology·R J Blanchard, D C Blanchard
Jul 14, 1999·Behavioural Brain Research·T J Gould, J M Wehner
Aug 23, 2003·Neurobiology of Learning and Memory·Thomas J Gould, J Stephen Higgins
May 28, 2005·Addictive Behaviors·Frances P ThorndikeDavid A F Haaga
Nov 2, 2005·Neuroscience Letters·Jennifer A DavisThomas J Gould
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sung-Wuk JangKeqiang Ye
Jun 5, 2010·Science·Jamie PetersGregory J Quirk
Dec 3, 2010·The American Journal of Psychiatry·Raul AnderoKerry J Ressler
Apr 26, 2012·Genes, Brain, and Behavior·R Andero, K J Ressler
Oct 9, 2013·Experimental and Clinical Psychopharmacology·Kirsten A Hawkins, Jesse R Cougle
Feb 4, 2014·Behavioural Brain Research·Munir G Kutlu, Thomas J Gould
Mar 15, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Luis E Rosas-VidalGregory J Quirk
Oct 2, 2014·Journal of Psychopharmacology·Munir G KutluThomas J Gould
Dec 22, 2015·Physiology & Behavior·Munir Gunes Kutlu, Thomas J Gould
Dec 22, 2015·Neurobiology of Learning and Memory·Munir Gunes KutluThomas J Gould
Jan 26, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jan HaakerRaffael Kalisch
Jul 5, 2017·Journal of Psychopharmacology·David A ConnorThomas J Gould

❮ Previous
Next ❯

Citations

Apr 16, 2020·Naunyn-Schmiedeberg's Archives of Pharmacology·Manish KumarAmteshwar Singh Jaggi

❮ Previous
Next ❯

Software Mentioned

PC
MED

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.